Cite
HARVARD Citation
Krasniqi, E. et al. (n.d.). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence. Journal of cellular physiology. 235 (11), pp. 7900-7910. [Online].